Header Logo

Connection

Tom Boyles to Humans

Back to Details
This is a "connection" page, showing publications Tom Boyles has written about Humans.
Tom Boyles
Connection Strength
1,541
Humans
  1. Outcomes of a model integrating tuberculosis testing into COVID-19 services in South Africa. Afr J Prim Health Care Fam Med. 2022 Dec 13; 14(1):e1-e4.
    View in: PubMed
    Score: 0,065
  2. Preparing healthcare facilities to operate safely and effectively during the COVID-19 pandemic: The missing piece in the puzzle. S Afr Med J. 2020 08 12; 110(9):835-836.
    View in: PubMed
    Score: 0,055
  3. Critical changes to services for TB patients during the COVID-19 pandemic. Int J Tuberc Lung Dis. 2020 05 01; 24(5):542-544.
    View in: PubMed
    Score: 0,054
  4. The infectious diseases specialty in South Africa is in crisis. S Afr Med J. 2019 08 28; 109(9):620-621.
    View in: PubMed
    Score: 0,052
  5. Antibiotic use and resistance: Knowledge, attitudes and perceptions among primary care prescribers in South Africa. S Afr Med J. 2018 Aug 28; 108(9):763-771.
    View in: PubMed
    Score: 0,048
  6. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV. Int J Infect Dis. 2018 Oct; 75:67-73.
    View in: PubMed
    Score: 0,048
  7. Xpert Ultra's place in the diagnosis of tuberculous meningitis. Lancet Infect Dis. 2018 03; 18(3):248-249.
    View in: PubMed
    Score: 0,047
  8. Determining clinical decision thresholds for HIV-positive patients suspected of having tuberculosis. Evid Based Med. 2017 Aug; 22(4):132-138.
    View in: PubMed
    Score: 0,045
  9. Brief Report: Flow Rate of Cerebrospinal Fluid Through a Spinal Needle Can Accurately Predict Intracranial Pressure in Cryptococcal Meningitis. J Acquir Immune Defic Syndr. 2017 03 01; 74(3):e64-e66.
    View in: PubMed
    Score: 0,044
  10. Why do clinical trials of Xpert® MTB/RIF fail to show an effect on patient relevant outcomes? Int J Tuberc Lung Dis. 2017 03 01; 21(3):249-250.
    View in: PubMed
    Score: 0,044
  11. Sustained reduction in antibiotic consumption in a South African public sector hospital; Four year outcomes from the Groote Schuur Hospital antibiotic stewardship program. S Afr Med J. 2017 Jan 30; 107(2):115-118.
    View in: PubMed
    Score: 0,043
  12. A priori estimation of diagnostic thresholds could improve the reporting of diagnostic studies of tuberculosis. Int J Tuberc Lung Dis. 2016 Feb; 20(2):147-9.
    View in: PubMed
    Score: 0,040
  13. Ebola: Personal view from the field--Sierra Leone. S Afr Med J. 2015 Nov 22; 105(12):1008-9.
    View in: PubMed
    Score: 0,040
  14. Diagnostic accuracy of tuberculin skin test self-reading by HIV patients in a low-resource setting. Int J Tuberc Lung Dis. 2015 Nov; 19(11):1300-4.
    View in: PubMed
    Score: 0,040
  15. Blood cultures taken from patients attending emergency departments in South Africa are an important antibiotic stewardship tool, which directly influences patient management. BMC Infect Dis. 2015 Oct 06; 15:410.
    View in: PubMed
    Score: 0,039
  16. Ceftolozane-tazobactam versus levofloxacin in urinary tract infection. Lancet. 2015 Sep 26; 386(10000):1241.
    View in: PubMed
    Score: 0,039
  17. The Individualised versus the Public Health Approach to Treating Ebola. PLoS Med. 2015 Jul; 12(7):e1001858.
    View in: PubMed
    Score: 0,039
  18. False-positive Xpert(®) MTB/RIF assays and previous treatment. Int J Tuberc Lung Dis. 2015 Apr; 19(4):495-6.
    View in: PubMed
    Score: 0,038
  19. Appropriate use of the Xpert® MTB/RIF assay in suspected tuberculous meningitis. Int J Tuberc Lung Dis. 2015 Mar; 19(3):276-7.
    View in: PubMed
    Score: 0,038
  20. Priorities in Ebola research--a view from the field. Lancet. 2015 Jan 03; 385(9962):23.
    View in: PubMed
    Score: 0,037
  21. False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results. Int J Tuberc Lung Dis. 2014 Jul; 18(7):876-8.
    View in: PubMed
    Score: 0,036
  22. Antibiotic stewardship ward rounds and a dedicated prescription chart reduce antibiotic consumption and pharmacy costs without affecting inpatient mortality or re-admission rates. PLoS One. 2013; 8(12):e79747.
    View in: PubMed
    Score: 0,035
  23. Noakes' low-carbohydrate, high-fat diet: call for evidence. S Afr Med J. 2013 Dec; 103(12):882-3.
    View in: PubMed
    Score: 0,035
  24. Test performance of beta-glucan for Pneumocystis jirovecii pneumonia put in a clinical context. AIDS. 2013 Jun 19; 27(10):1679.
    View in: PubMed
    Score: 0,034
  25. The pros and cons of urinary lipoarabinomannan testing. AIDS. 2012 Nov 13; 26(17):2263-4; author reply 2264-5.
    View in: PubMed
    Score: 0,032
  26. Failure to eradicate Isospora belli diarrhoea despite immune reconstitution in adults with HIV--a case series. PLoS One. 2012; 7(8):e42844.
    View in: PubMed
    Score: 0,032
  27. Should tuberculin skin testing be a prerequisite to prolonged IPT for HIV-infected adults? Int J Tuberc Lung Dis. 2012 Jul; 16(7):857-9.
    View in: PubMed
    Score: 0,031
  28. Timing of antiretroviral therapy for HIV-1-associated tuberculosis. N Engl J Med. 2012 02 02; 366(5):474-5; author reply 476.
    View in: PubMed
    Score: 0,031
  29. The prevalence of hepatitis B infection in a rural South African HIV clinic. S Afr Med J. 2011 Jun 27; 101(7):470-1.
    View in: PubMed
    Score: 0,029
  30. HIV counselling and testing in South African schools. Lancet. 2011 May 21; 377(9779):1748.
    View in: PubMed
    Score: 0,029
  31. Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme. PLoS One. 2011 May 03; 6(5):e19201.
    View in: PubMed
    Score: 0,029
  32. Emergency medical services--poor response time in the rural Eastern Cape. S Afr Med J. 2010 Nov 30; 100(12):790.
    View in: PubMed
    Score: 0,028
  33. A validated method for quantifying macrovesicular hepatic steatosis in chronic hepatitis C. Anal Quant Cytol Histol. 2007 Aug; 29(4):244-50.
    View in: PubMed
    Score: 0,022
  34. Pneumocystis jirovecii pneumonia in people living with HIV: a review. Clin Microbiol Rev. 2024 03 14; 37(1):e0010122.
    View in: PubMed
    Score: 0,018
  35. Treating drug-resistant tuberculosis in an era of shorter regimens: Insights from rural South Africa. S Afr Med J. 2023 Nov 06; 113(11):47-56.
    View in: PubMed
    Score: 0,017
  36. The therapeutic threshold in clinical decision-making for TB. Int Health. 2023 11 03; 15(6):615-622.
    View in: PubMed
    Score: 0,017
  37. Guidelines for Diagnosis and Management of Infective Endocarditis in Adults: A WikiGuidelines Group Consensus Statement. JAMA Netw Open. 2023 07 03; 6(7):e2326366.
    View in: PubMed
    Score: 0,017
  38. Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis. Eur Respir Rev. 2023 Jun 30; 32(168).
    View in: PubMed
    Score: 0,017
  39. Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study. Clin Infect Dis. 2021 12 06; 73(11):e3842-e3850.
    View in: PubMed
    Score: 0,015
  40. Diagnostic Accuracy of the INSHI Consensus Case Definition for the Diagnosis of Paradoxical Tuberculosis-IRIS. J Acquir Immune Defic Syndr. 2021 04 15; 86(5):587-592.
    View in: PubMed
    Score: 0,014
  41. Consensus study on the health system and patient-related barriers for lung cancer management in South Africa. PLoS One. 2021; 16(2):e0246716.
    View in: PubMed
    Score: 0,014
  42. A threat to decentralised care for drug-resistant tuberculosis. Lancet Respir Med. 2020 10; 8(10):950-952.
    View in: PubMed
    Score: 0,014
  43. Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts' consensus recommendations. Eur J Clin Microbiol Infect Dis. 2019 Sep; 38(9):1581-1584.
    View in: PubMed
    Score: 0,013
  44. Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial. Lancet HIV. 2019 07; 6(7):e428-e437.
    View in: PubMed
    Score: 0,013
  45. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. JAMA. 2018 09 11; 320(10):984-994.
    View in: PubMed
    Score: 0,012
  46. The management and outcomes of Staphylococcus aureus bacteraemia at a South African referral hospital: A prospective observational study. Int J Infect Dis. 2018 Aug; 73:78-84.
    View in: PubMed
    Score: 0,012
  47. The role of appropriate diagnostic testing in acute respiratory tract infections: An antibiotic stewardship strategy to minimise diagnostic uncertainty in primary care. S Afr Med J. 2016 May 10; 106(6):30-7.
    View in: PubMed
    Score: 0,010
  48. Raised Venous Lactate and Markers of Intestinal Translocation Are Associated With Mortality Among In-Patients With HIV-Associated TB in Rural South Africa. J Acquir Immune Defic Syndr. 2015 Dec 01; 70(4):406-13.
    View in: PubMed
    Score: 0,010
  49. Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infect Dis. 2015 Sep; 15(9):1024-1033.
    View in: PubMed
    Score: 0,010
  50. Ebola and provision of critical care. Lancet. 2015 Apr 11; 385(9976):1392.
    View in: PubMed
    Score: 0,010
  51. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015. Euro Surveill. 2015 Mar 26; 20(12).
    View in: PubMed
    Score: 0,010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.